(Q36013688)

11 August 2017

1 reference

title

Pneumocystis jiroveci pneumonia in adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy (English)

1 reference

11 August 2017

0 references

0 references

Naimish Patel

1

1 reference

11 August 2017

Henry Koziel

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2004

1 reference

Treatments in Respiratory Medicine

11 August 2017

published in

1 reference

11 August 2017

volume

3

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

381-397

1 reference

Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Pneumocystis carinii Pneumonia: A Cluster of Eleven Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Inflammatory Responses to Pneumocystis carinii in Mice Selectively Depleted of Helper T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Serologic responses to Pneumocystis carinii antigens in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Pneumocystis carinii infection in transgenic B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Pneumocystis carinii pneumonia: diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Community-acquired pneumonia: impact of immune status

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

The laboratory evaluation of opportunistic pulmonary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Dihydropteroate synthase polymorphisms in Pneumocystis carinii

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Current issues in the use of theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Oral Atovaquone Compared with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Salvage Therapy with Clindamycin/Primaquine for Pneumocystis carinii Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

Clindamycin and Primaquine Therapy for Mild-to-Moderate Episodes of Pneumocystis carinii Pneumonia in Patients with AIDS: AIDS Clinical Trials Group 044

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403060-00005

10.2165/00151829-200403060-00005

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1033635976

0 references

1 reference